Core Laboratories N.V Stock Hits New 52-Week High (CLB)
Core Laboratories N.V (NYSE:CLB) hit a new 52-week high Thursday as it is currently trading at $153.45, above its previous 52-week high of $147.96 with 2,997 shares traded as of 9:40 a.m. ET. Average volume has been 280,900 shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Core Laboratories N.V (NYSE: CLB) hit a new 52-week high Thursday as it is currently trading at $153.45, above its previous 52-week high of $147.96 with 2,997 shares traded as of 9:40 a.m. ET. Average volume has been 280,900 shares over the past 30 days. Core Laboratories N.V has a market cap of $6.93 billion and is part of the basic materials sector and energy industry. Shares are up 39.6% year to date as of the close of trading on Wednesday. Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company has a P/E ratio of 32.3, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Core Laboratories N.V Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..